Streetbeat News

Analyst Ratings

PNR

TD Cowen analyst Joseph Giordano maintains an Outperform rating on Pentair (NYSE:PNR) and raises the price target from $65 to $75.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 1:06 pm

WINT

Windtree Therapeutics, Inc. (NASDAQ:WINT) is developing istaroxime, a treatment for acute heart failure and cardiogenic shock, and is advancing to the next stage of development after three successful phase 2 trials. The company is also developing a next-generation drug platform based on SERCA2a activators. Windtree recently raised $12.4 million in a public stock offering and received a patent allowance from the USPTO for its dual mechanism SERCA2a activators. The company's Q1 2023 R&D expenses were $1.5 million, down from $5.3 million in Q1 2022.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 1:05 pm

GBIO

JP Morgan analyst Anupam Rama maintains a Neutral rating on Generation Bio (NASDAQ:GBIO) and raises the price target from $8 to $9.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 1:02 pm

CAH

JP Morgan analyst Lisa Gill maintains a Neutral rating on Cardinal Health (NYSE:CAH) and raises the price target from $93 to $101.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 1:01 pm

MEC

Over the past three months, four analysts have published their opinions on Mayville Engineering (NYSE:MEC) stock. The majority of these ratings are bullish, with an average price target of $20.5, compared to the current price of $11.98. This represents a 2.38% decrease from the previous average price target of $21.00.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 1:01 pm

MTDR

Analysts have provided bullish and somewhat bullish ratings for Matador Resources (NYSE:MTDR) in the last quarter. The average price target of $69.0 implies an upside from the current price of $57.82. The current average has increased by 0.73% from the previous average price target of $68.50.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 1:00 pm

PSFE

Over the past 3 months, 5 analysts have published their opinion on Paysafe (NYSE:PSFE) stock. The analysts have an average price target of $25.54 versus the current price of Paysafe at $14.64, implying an upside. This current average has decreased by 11.01% from the previous average price target of $28.70.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 1:00 pm

CAH

In the last quarter, 10 analysts have provided ratings for Cardinal Health (NYSE:CAH), with 1 bullish, 2 somewhat bullish, and 7 indifferent. The company has an average 12-month price target of $96.3, up by 5.82% from the previous average of $91.00.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 1:00 pm

INTR

Inter & Co (NASDAQ:INTR) has received 5 bullish ratings from analysts in the last quarter. The company's average 12-month price target is $5.04, with a high of $5.50 and a low of $4.40. This average price target has increased by 31.25% over the past month.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 1:00 pm

AEE

JP Morgan analyst Jeremy Metz maintains an Overweight rating on Ameren (NYSE:AEE) and raises the price target from $94 to $95.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 1:00 pm